Treatment for management and prevention of eyelid conditions
OwnerJohn Olkowski, Erika Olkowskiinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerJohn Olkowski, Erika Olkowskiinventors
Estimating the term…
Blepharitis, an infection and inflammation of the edge of the eyelids, and meibomian gland dysfunction (MGD), blockage of tiny oil glands at the eye lid margin, are quite common, usually under diagnosed and underappreciated diseases. There are number of causes for blepharitis, including bacterial components such as Staphylococcus aureus, Staphylococcus epidermidis, Propionibacterium acnes and Corynebacteria sp., seborrhea or microscopic mites (Demodex). More than 50% of patients seeking ophthalmologic consultations have symptoms and signs indicating one of these entities. Another large number of patients remain undiagnosed or in early stages of disease that could be easily treated thus preventing long-term pain and suffering. MGD is in fact the leading cause of dry eye disease, a potentially preventable malady.
A composition for treating eyelid conditions, comprising:
A method of treating an eyelid condition, comprising:
A kit for treating an eyelid condition, comprising:
Dependencies are inferred from the claim text.